{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SHPH/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T13:08:14.315Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4391,"canonical_name":"Shuttle Pharmaceuticals Holdings, Inc.","cik":"0001757499","uei":null,"lei":null,"duns":null,"ticker":"SHPH"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":30},"count":30,"timeline":[{"ts":"2026-09-24","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Shuttle Pharmaceuticals Holdings, Inc. — 2026-09-24","url_slug":"/sec/cik-0001757499/10-q/0001493152-26-044107","accession_number":"0001493152-26-044107","importance":45},{"ts":"2026-09-24","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Shuttle Pharmaceuticals Holdings, Inc. — 2026-09-24","url_slug":"/sec/cik-0001757499/8-k-a/0001493152-26-044106","accession_number":"0001493152-26-044106","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Shuttle Pharmaceuticals Holdings, Inc. — 2026-09-16","url_slug":"/sec/cik-0001757499/8-k/0001493152-26-042791","accession_number":"0001493152-26-042791","importance":35},{"ts":"2026-09-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Shuttle Pharmaceuticals Holdings, Inc. — 2026-09-11","url_slug":"/sec/cik-0001757499/8-k/0001493152-26-042299","accession_number":"0001493152-26-042299","importance":35},{"ts":"2026-09-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Shuttle Pharmaceuticals Holdings, Inc. — 2026-09-02","url_slug":"/sec/cik-0001757499/8-k/0001493152-26-041213","accession_number":"0001493152-26-041213","importance":35},{"ts":"2026-09-02","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Shuttle Pharmaceuticals Holdings, Inc. — 2026-09-02","url_slug":"/sec/cik-0001757499/defa14a/0001493152-26-041214","accession_number":"0001493152-26-041214","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Shuttle Pharmaceuticals Holdings, Inc. — 2026-09-01","url_slug":"/sec/cik-0001757499/8-k/0001493152-26-041011","accession_number":"0001493152-26-041011","importance":35},{"ts":"2026-08-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Shuttle Pharmaceuticals Holdings, Inc. — 2026-08-28","url_slug":"/sec/cik-0001757499/8-k/0001493152-26-040622","accession_number":"0001493152-26-040622","importance":35},{"ts":"2026-08-17","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Shuttle Pharmaceuticals Holdings, Inc. — 2026-08-17","url_slug":"/sec/cik-0001757499/8-k-a/0001493152-26-038786","accession_number":"0001493152-26-038786","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"NT 10-Q","title":"NT 10-Q — Shuttle Pharmaceuticals Holdings, Inc. — 2026-08-17","url_slug":"/sec/cik-0001757499/nt-10-q/0001493152-26-038790","accession_number":"0001493152-26-038790","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Shuttle Pharmaceuticals Holdings, Inc. — 2026-08-13","url_slug":"/sec/cik-0001757499/def-14a/0001493152-26-037821","accession_number":"0001493152-26-037821","importance":40},{"ts":"2026-08-13","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Shuttle Pharmaceuticals Holdings, Inc. — 2026-08-13","url_slug":"/sec/cik-0001757499/defa14a/0001493152-26-037827","accession_number":"0001493152-26-037827","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Shuttle Pharmaceuticals Holdings, Inc. — 2026-08-03","url_slug":"/sec/cik-0001757499/pre-14a/0001493152-26-035855","accession_number":"0001493152-26-035855","importance":30},{"ts":"2026-07-14","kind":"sec.insider.s","reporter":"HRT FINANCIAL LP","title":null,"shares":82116,"price_per_share":4.48,"usd_value":367880,"security_title":"Common Stock","importance":35.36787968},{"ts":"2026-07-13","kind":"sec.insider.s","reporter":"HRT FINANCIAL LP","title":null,"shares":1033,"price_per_share":4.67,"usd_value":4824,"security_title":"Common Stock","importance":35.00482411},{"ts":"2026-07-10","kind":"sec.insider.p","reporter":"HRT FINANCIAL LP","title":null,"shares":731,"price_per_share":3.11,"usd_value":2273,"security_title":"Common Stock","importance":50.00227341},{"ts":"2026-07-09","kind":"sec.insider.p","reporter":"HRT FINANCIAL LP","title":null,"shares":8266,"price_per_share":3.38,"usd_value":27939,"security_title":"Common Stock","importance":50.02793908},{"ts":"2026-07-08","kind":"sec.insider.s","reporter":"HRT FINANCIAL LP","title":null,"shares":18531,"price_per_share":3.52,"usd_value":65229,"security_title":"Common Stock","importance":35.06522912},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"HRT FINANCIAL LP","title":null,"shares":10580,"price_per_share":3.33,"usd_value":35231,"security_title":"Common Stock","importance":35.0352314},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"HRT FINANCIAL LP","title":null,"shares":9022,"price_per_share":3.51,"usd_value":31667,"security_title":"Common Stock","importance":35.03166722},{"ts":"2026-07-02","kind":"sec.insider.p","reporter":"HRT FINANCIAL LP","title":null,"shares":7851,"price_per_share":3.54,"usd_value":27793,"security_title":"Common Stock","importance":50.02779254},{"ts":"2026-07-01","kind":"sec.insider.p","reporter":"HRT FINANCIAL LP","title":null,"shares":3959,"price_per_share":3.3,"usd_value":13065,"security_title":"Common Stock","importance":50.0130647},{"ts":"2026-07-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Shuttle Pharmaceuticals Holdings, Inc. — 2026-07-01","url_slug":"/sec/cik-0001757499/8-k/0001493152-26-031375","accession_number":"0001493152-26-031375","importance":35},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"HRT FINANCIAL LP","title":null,"shares":6755,"price_per_share":3.23,"usd_value":21819,"security_title":"Common Stock","importance":50.02181865},{"ts":"2026-06-29","kind":"sec.insider.p","reporter":"HRT FINANCIAL LP","title":null,"shares":25836,"price_per_share":3.44,"usd_value":88876,"security_title":"Common Stock","importance":50.08887584},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Shuttle Pharmaceuticals Holdings, Inc. — 2026-06-11","url_slug":"/sec/cik-0001757499/8-k/0001493152-26-028301","accession_number":"0001493152-26-028301","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"3","title":"3 — Shuttle Pharmaceuticals Holdings, Inc. — 2026-06-01","url_slug":"/sec/cik-0001757499/3/0001493152-26-026694","accession_number":"0001493152-26-026694","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Shuttle Pharmaceuticals Holdings, Inc. — 2026-05-15","url_slug":"/sec/cik-0001757499/10-q/0001493152-26-023859","accession_number":"0001493152-26-023859","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"D","title":"D — Shuttle Pharmaceuticals Holdings, Inc. — 2026-05-15","url_slug":"/sec/cik-0001757499/d/0001493152-26-023887","accession_number":"0001493152-26-023887","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Shuttle Pharmaceuticals Holdings, Inc. — 2026-05-12","url_slug":"/sec/cik-0001757499/defa14a/0001493152-26-022491","accession_number":"0001493152-26-022491","importance":30}]}